Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel after paclitaxel-eluting femoropopliteal stent implantation
2014-004298-18Phase 3Active
- Sponsor
- AUSL 8
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in arteriosclerosis obliterans and femoropopliteal disease comparing Ticagrelor arm with Clopidogrel arm (2 arms). Primary endpoint: Net percentage volume obstruction. Started Nov 2014; status: active.
02
Drugs
ticagrelorclopidogrel
03
Conditions
arteriosclerosis obliteransfemoropopliteal disease
Beyond the preview
Go deeper on 2014-004298-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004298-18.